Icosavax
Brendan Mullin has been working in the quality assurance and control field since 2011. Brendan began their career at Ipsen as a Manufacturing Associate I. In 2013, they joined Baxter International Inc. as a Quality Control Analyst I - Analytical Chemistry and a Manufacturing Associate II. In 2015, they moved to Baxalta as a Quality Control Analyst II - Analytical Chemistry and a Quality Control Analyst I - Analytical Chemistry. In 2017, they joined Moderna Therapeutics as a Senior Quality Control Associate. Most recently, in 2021, they became a Quality Assurance Manager at Icosavax, Inc.
Brendan Mullin attended Villanova University from 2006 to 2010, where they obtained a Bachelor of Science in Biology, General.
This person is not in any offices
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs.